Nanoparticulate fibrate formulations

Pharmaceutical formulations

Alcohol Resistant Dosage Forms

Osmotic drug delivery system

Metaxalone formulations and methods for the preparation thereof

SOLID PHARMACEUTICAL DOSAGE FORM

Solid dispersion preparation

Dosage Forms Containing A PPI, NSAID, and Buffer

Novel formulation of pyridoxal-5'-phosphate and method of preparation

Oral dosage forms including an antiplatelet agent and an acid inhibitor

Nicotinic Acid Compositions For Treating Hyperlipidemia and Related Methods Therefor

Method for preparing free base compositions and formulations thereof

Nicotinic Acid Compositions For Treating Hyperlipidemia and Related Methods Therefor

Nicotinic Acid Compositions For Treating Hyperlipidemia and Related Methods Therefor

Sustained-Release Preparations Containing Topiramate and the Producing Method Thereof

Nicotinic Acid Compositions For Treating Hyperlipidemia and Related Methods Therefor

Controlled Release Pharmaceutical Formulation

Process for preparing oral calcium compositions

SIMVASTATIN COMPOSITIONS

Sustained release matrix systems for highly soluble drugs

Solid Dispersible and/or Orodispersible Non-Filmy Containing at Least One Type of Active Substance Pharmaceutical Composition and Method for the Preparation Thereof

Modified release formulations containing drug-ion exchange resin complexes

Controlled Release Matrix Pharmaceutical Dosage Formulation

SUSTAINED-RELEASE TABLET CONTAINING DOXAZOSIN MESYLATE

Composition containing benzamidine derivative and method for stabilizing benzamidine derivative

PHARMACEUTICAL FORMULATIONS OF A MONOHYDRATE CRYSTAL FORM OF 2-(3-FLUORO-4-HYDROXYPHENYL)-7-VINYL-1,3-BENZOXAZOL-5-OL

Tamper resistant dosage form comprising an adsorbent and an adverse agent

Pharmaceutical composition and process

Andrographis Extract Formulations

EXTENDED RELEASE PHARMACEUTICAL COMPOSITIONS

DRUG DELIVERY SYSTEMS COMPRISING WEAKLY BASIC DRUGS AND ORGANIC ACIDS

Sustained release formulation for oral administration of HMG-CoA reductase inhibitor and method for the preparation thereof

Micronized Eplerenone Compositions

DRUG DELIVERY SYSTEMS COMPRISING WEAKLY BASIC SELECTIVE SEROTONIN 5-HT3 BLOCKING AGENT AND ORGANIC ACIDS

Multilayer tablet

Delayed release pharmaceutical oral dosage form and method of making same

Stabilized atorvastatin

Process for producing fenofibrate tablets

Sustained release dosage forms of ziprasidone

Pharmaceutical formulations of aliphatic amine polymers and methods for their manufacture

Controlled release formulation for oral administration of metformin

Pharmaceutical formulations

Stable oral compositions of azithromycin monohydrate

Stable pharmaceutical formulations of montelukast sodium

Moisture resistant container systems for rapidly bioavailable dosage forms

Blister packaging for acute pain regimens

Process for producing fenofibrate tablets

Stable pharmaceutical formulations of montelukast sodium

DOSAGE FORM THAT IS SAFEGUARDED FROM ABUSE

Pharmaceutical formulations of oxcarbazepine and methods for its preparation

Levodopa compositions

Oral ribavirin pharmaceutical compositions

Anti-diabetic combinations

Oral ribavirin pharmaceutical compositions

Pharmaceutical preparations for treating hypertension and dyslipidemia with Allium ursinum and Allium sativum

Nanoparticulate and controlled release compositions comprising a cephalosporin

Compression-coated tablets and manufacture thereof

Delayed release carnitine

Prolonged release bioadhesive therapeutic systems

Controlled release formulation of divalproex sodium

Multiparticulate formulations for oral delivery

Gastric release pulse system for drug delivery

Dry formulations of aripiprazole

Wet formulations of aripiprazole

Solid ganaxolone formulations and methods for the making and use thereof

Compressed solid dosage forms with drugs of low solubility and process for making the same

SUSTAINED-RELEASE FORMULATION OF ZONISAMIDE

Pharmaceutical formulations

Medicament-containing particle and a solid preparation containing the particle

PROCESSES FOR MAKING PARTICLE-BASED PHARMACEUTICAL FORMULATIONS FOR ORAL ADMINISTRATION

Liquid ganaxolone formulations and methods for the making and use thereof

Antidiabetic formulation and method

Pharmaceutical composition

SEQUENTIAL RELEASE PHARMACEUTICAL FORMULATIONS

Oral paracetamol formulations

Orally administrable extended release pellet and tablet formulations of a highly water soluble compound

Pharmaceutical formulations

Pharmaceutical or dietary compositions based on short-chain fatty acids and complex sugars, for intestinal disorders

Process for manufacturing chewable dosage forms for drug delivery and products thereof

Method for preparing modified release pharmaceutical compositions

Storage stable thyroxine active drug formulations and methods for their production

Synergistic binder composition, method for making same, and tablets of an active and said binder having advantageous hardness and friability

RAPIDLY ABSORBING ORAL FORMULATIONS OF PDE 5 INHIBITORS

Pharmaceutical formulation with improved stability

Extended release osmo-microsealed formulation

Initiated chemical vapor deposition of vinyl polymers for the encapsulation of particles

TABLETS OF LINEZOLID FORM III AND PROCESSES FOR THEIR PREPARATION

Unitary pharmaceutical dosage form

Compositions and methods for the administration clozapine formulations which modulate body weight

Compositions and methods for the administration psychotropic drugs which modulate body weight

STABILIZED EXTENDED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A BETA-ADRENORECEPTOR ANTAGONIST

Extended release formulation of Levetiracetam

EFFERVESCENT FORMULATIONS OF OXYTOCIN

Effervescent bisphosphonate formulation

Banded controlled release nanoparticle active agent formulation dosage forms and methods

Pharmaceutical Preparation containing Meloxicam

Method and composition for pharmaceutical product

Vaginal tablets comprising misoprostol and methods of making and using the same

Novel dosage formulation

Novel controlled release delivery device for pharmaceutical agents incorporating microbial polysaccharide gum

Drug Delivery System and Associated Methods

WATER-DISPERSIBLE ANTI-RETROVIRAL PHARMACEUTICAL COMPOSITIONS

Sustained release oral formulations

Nanoparticulate anticonvulsant and immunosuppressive compositions

Drug compositions containing controlled release hypromellose matrices

Free flowing granules containing carbomer

High drug load formulations and dosage forms

Treatment of allergic conditions

Rapidly absorbing oral formulations of PDE 5 inhibitors

Pharmaceutical co-crystal compositions

Magnesium salt proton pump inhibitor dosage forms

Oral pharmaceutical delivery system with improved sustained release

Solid, modified-release pharmaceutical dosage forms which can be administered orally

Tablet comprising a fibrate

Sustained release pharmaceutical compositions for highly water soluble drugs

Methods of formulating linezolid

PHARMACEUTICAL COMPOSITIONS COMPRISING FENOFIBRATE AND ATORVASTATIN

Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritant agent

Compositions comprising fenofibrate and atorvastatin

EXTENDED RELEASE COMPOSITIONS

Free-flowing solid formulations with improved bio-availability of poorly water soluble drugs and process for making the same

Sustained-release tramadol formulations with 24-hour efficacy

Nanoparticulate clopidogrel and aspirin combination formulations

Composition containing medicine extremely slightly soluble in water being excellent in eluting property and method for preparation thereof

Modified release compositions comprising tacrolimus

Pharmaceutical formulation comprising a pyrimidine-a-one derivative coated with an enteric polymer

Tanaproget compositions containing ethinyl estradiol

Pharmaceutical formulations

Pharmaceutical formulations

STABLE GRANULATES CONTAINING S-ADENOSYLMETHIONINE AND PROCESS FOR PREPARATION THEREOF

Controlled release tramadol formulations

Antifungal compositions with improved bioavailability

Pharmaceutical compositions comprising clavulanic acid

Free-flowing solid formulations with improved bio-availability of poorly water soluble drugs and process for making the same

Process of making crystalline Type II aripiprazole

Coated tablets

Pharmaceutical tablets of crystalline type II aripiprazole

Localized controlled absorption of statins in the gastrointestinal tract for achieving high blood levels of statins

Compressed solid dosage form manufacturing process well-suited for use with drugs of low aqueous solubility and compressed solid dosage forms made thereby

SYSTEMS, METHODS AND APPARATUSES FOR MANUFACTURING DOSAGE FORMS

Micronized tanaproget, compositions, and methods of preparing the same

Modified release dosage form

Taste masked sumatriptan tablets and processes for their preparation

Controlled release venlafaxine formulations

Pharmaceutical compositions having improved dissolution profiles for poorly soluble drugs

Solid preparation comprising an insulin sensitizer, an insulin secretagogue and a polyoxyethylene sorbitan fatty acid ester

Novel olanzapine forms and related methods of treatment

Pharmaceutical composition and preparation method thereof

Method of protecting sensitive molecules from a photo-polymerizing environment

Sustained release ranolazine formulations

Rapid-acting pharmaceutical composition

Stable tablet dosage forms of proton pump inhibitors

Co-precipitated amorphous losartan and dosage forms comprising the same

Dual controlled release dosage form

Roflumilast and integrin inhibitor combination and treatement method

5-(4-(2-N-methyl-N-(2-pyridyl)amido)ethoxy)benzyl) thiazolidine-2,4-dione and pharmaceutical compositions comprising the same

Controlled release O-desmethylvenlafaxine formulations

Controlled release venlafaxine formulations

Extended release formulations of poorly soluble antibiotics

5-(4-(2-N-methyl-N-(2-pyridyl)amido)ethoxy)benzyl thiazolidine - 2,4-dione and pharmaceutical compositions comprising the same

Pharmaceutical compositions of ganciclovir

Carvedilol free base, salts, anhydrous forms or solvates thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods

Impregnated powder improving bioavailability and/or solubility and method of production

Fast disintegrating tablet

Bambuterol and integrin inhibitor combination and treatment method

Gellan gum based oral controlled release dosage forms-a novel platform technology for gastric retention

Extended release formulation of levetiracetam

Lercanidipine modified release compositions

Lercanidipine pH dependent pulsatile release compositions

Method for deterring abuse of opioids by combination with non-release formulation of emetic

Stable non-crystalline formulation comprising losartan

Method to obtain microparticles containing an H+,K+-ATP-ASE inhibitor

Controlled release and taste masking oral pharmaceutical composition

Oral immediate release formulation of a poorly water-soluble active substance

Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof

Stabilized individually coated ramipril particles, compositions and methods

Novel dosage form

Sustained-release preparations and method for producing the same

Sustained release compositions containing alfuzosin

Granulate comprising an oily substance, corresponding production method and tablet

Sustained release ranolazine formulations

Process for the preparation of robust formulations of valacyclovir hydrochloride tablets

Orally disintegrating pharmaceutical compositions with sensory cue agents

Leukotriene and integrin inhibitor combination and treatment method

Stabilized ramipril compositions and methods of making

Controlled release and taste masking oral pharmaceutical composition

Oral compositions for treatment of diseases

Preparation and administration form comprising an acid-labile active compound

Fast-melting tablets having taste-masking and sustained release properties

Bilayer tablet of telmisartan and amlodipine

Deferacirox dispersible tablets

Dispersible tablet for oral administration

Compositions comprising fenofibrate and simvastatin

Taste-masked pharmaceutical compositions prepared by coacervation

Threo-dops controlled release formulation

Sustained release heterodisperse hydrogel systems for insoluble drugs

Fast dissolving and taste masked oral dosage form comprising sildenafil

Compressed solid dosage form manufacturing process well-suited for use with drugs of low aqueous solubility and compressed solid dosage forms made thereby

Use of an aqueous solution of citric acid and a water-soluble sugar like lactitol as granulation liquid in the manufacture of tablets

Stabilized pharmaceutical composition comprising antidiabetic agent

Highly compressible controlled delivery compositions of metformin

Taste masking pharmaceutical composition containing levocetirizine

Pharmaceutical formulations containing microparticles or nanoparticles of a delivery agent

Pharmaceutical formulations containing microparticles or nanoparticles of a delivery agent

Taste-masked pharmaceutical compositions

Solid dosage form comprising a fibrate and a statin

Method for improving the bioavailability of orally delivered therapeutics

Taste-masking coated particles, process for the preparation thereof and orodispersible tablets containing said coated particles

Pharmaceutical compositions containing venlafaxine

Process of manufacture of novel drug delivery system: multilayer tablet composition of thiazolidinedione and biguanides

Orally disintegrating tablets of atomoxetine

Stable pharmaceutical formulations of benzimidazole compounds

Modified release formulations of memantine oral dosage forms

Abuse resistent pharmaceutical dosage and method of making same

Controlled regional oral delivery

Tamper-resistant oral opioid agonist formulations

Gabapentin tablets and method for their preparation

Abuse-proofed oral dosage form

Means of delivering drugs in an ascending zero order release pattern

Effervescent bisphosphonate formulation

Effervescent formulations of oxytocin

High ibuprofen content granules and their preparation and their use in pharmaceutical dosage forms

Sustained release L-arginine formulations and methods of manufacture and use

Dosage form for high dose-high solubility active ingredients that provides for immediate release and modified release of the active ingredients

Delayed release carnitine

Intimate coating of ibuprofen with poloxamers to enhance aqueous dissolution

Delayed release formulations of 6-mercaptopurine

Pharmaceutical compositions with synchronized solubilizer release

Oral pharmaceutical compositions in timed-release particle form and fast-disintegrating tablets containing this composition

Sustained release L-arginine formulations and methods of manufacture and use

Therapy using a combination of raloxifene and alendronate

Promethazine containing dosage form

Nanoparticulate fibrate formulations

Sustained release aminopyridine composition

Oral delivery system

Palatable controlled-release formulation for companion animals

Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them

Carvedilol formulations

Sustained release, mucoadhesive vaginal pharmaceutical compositions

Combination of proton pump inhibitor, buffering agent, and nonsteroidal anti-inflammatory drug

Compositions and methods for treating hepatitis C virus (HCV) infection

Polymeric drug delivery system for hydrophobic drugs

Methods and compositions for the treatment of CNS-related conditions

Pharmaceutical preparation containing oxycodone and naloxone

High-purity composition comprising (7a,17a)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one and a process for purifying (7a,17a)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one

Matrix for sustained, invariant and independent release of active compounds

Dosing methods for beta-D-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine antiviral therapy

Natural immunostimulant compositions, methods for obtaining the same and pharmaceutical formulations thereof

Amino acid modulated extended release dosage form

Quickly disintegrating solid preparations

Process for the production of an abuse-proofed solid dosage form

Dosage form containing promethazine and another drug

Proton pump inhibitor formulations, and methods of preparing and using such formulations

Storage stable thyroxine active drug formulations and methods for their production

Donepezil formulations

Process for preparing oral calcium compositions

Dosage form containing a morphine derivative and another drug

Dosage form containing promethazine and another drug

Particulate compositions

Compressed composition comprising magnesium salt

Molecular dispersions of drospirenone

Controlled release formulations using intelligent polymers

Prolonged release bioadhesive therapeutic systems

Pharmaceutical composition having a delayed active substance release, and method for the preparation thereof

Bioadhesive polymers with catechol functionality

Oral medicinal product with modified release of at least one active principle in multimicrocapsular form

Fast dissolving tablet and method of preparing the same

Stable pharmaceutical formulation of paroxetine hydrochloride anhydrous and a process for preparation thereof

Cushioning wax beads for making solid shaped articles

Solid formulations of ospemifene

Lypohilization product

Pharmaceutical compositions of quinapril

Synergistic antibacterial formulation and to a method of making the same

Tamper-resistant oral opioid agonist formulations

Sustained release oral formulations

Carvedilol free base, salts, anhydrous forms or solvates thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods

Particulate materials

Carvedilol free base, salts, anhydrous forms or solvates thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods

Fast disintegrating tablets

Stable pharmaceutical compositions containing pravastatin

Analgetic dosage forms that are resistant to parenteral and inhalation dosing and have reduced side effects

Clarithromycin formulations having improved bioavailability

Drug delivery system for averting pharmacokinetic drug interaction and method thereof

Process for the preparation of tablets from pharmaceutically active substances having unfavourable tabletting properties with a granulating liquid comprising microcrystalline cellulose

Antiaging composition

Sustained release ranolazine formulations

Systems, methods and apparatuses for manufacturing dosage forms

Rapid dissolution formulation of a calcium receptor-active compound

Solid pharmaceutical dosage formulation

Pharmaceutical dosage forms comprising tablet core having a tensile strength below 38 n/sqcm and a coating to protect the soft core

Oral peptide delivery system with improved bioavailability

Systems, methods and apparatuses for manufacturing dosage forms

Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes

Sustained/controlled release solid formulation as a novel drug delivery system with reduced risk of dose dumping

Nicotinic acid compositions for treating hyperlipidemia and related methods therefor

Bupropion formulation for sustained delivery

Ibuprofen and narcotic analgesic compositions

Stabilized azithromycin compositions

Nsaid formulation comprising a granular composition and an extra-granular composition

Pharmaceutical superdisintegrant